NX-2127: A First-Inclass Clinical Stage Degrader of BTK and IKZF1/3 for the Treatment of Patients with B Cell MalignanciesJeffrey T. Mihalic,Nivetha Brathaban,Brandon Bravo,Timothy Ingallinera,Daisuke Kato,Hao Lu,Jun Ma,Joel McIntosh,Austin Tenn-McClellan,Ratul Mukerji,Mark A. Noviski,Ge Peng,Luz Perez,Ryan Rountree,May Tan,Jeffrey Wu,Jordan Ye,Stephanie YungCANCER RESEARCH（2023）引用 2|浏览11关键词BTK InhibitorsAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
